Does BREXUCABTAGENE AUTOLEUCEL Cause Off label use? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Off label use have been filed in association with BREXUCABTAGENE AUTOLEUCEL (TECARTUS). This represents 1.1% of all adverse event reports for BREXUCABTAGENE AUTOLEUCEL.
20
Reports of Off label use with BREXUCABTAGENE AUTOLEUCEL
1.1%
of all BREXUCABTAGENE AUTOLEUCEL reports
5
Deaths
10
Hospitalizations
How Dangerous Is Off label use From BREXUCABTAGENE AUTOLEUCEL?
Of the 20 reports, 5 (25.0%) resulted in death, 10 (50.0%) required hospitalization, and 4 (20.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BREXUCABTAGENE AUTOLEUCEL. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does BREXUCABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (827)
Immune effector cell-associated neurotoxicity syndrome (529)
Neurotoxicity (192)
Death (153)
Pyrexia (119)
Hypotension (109)
Disease progression (93)
Fatigue (86)
Febrile neutropenia (69)
Confusional state (63)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which BREXUCABTAGENE AUTOLEUCEL Alternatives Have Lower Off label use Risk?
BREXUCABTAGENE AUTOLEUCEL vs BRIGATINIB
BREXUCABTAGENE AUTOLEUCEL vs BRILINTA
BREXUCABTAGENE AUTOLEUCEL vs BRILIQUE
BREXUCABTAGENE AUTOLEUCEL vs BRIMONIDINE
BREXUCABTAGENE AUTOLEUCEL vs BRIMONIDINE\BRINZOLAMIDE